Latest type of biological therapy, monoclonal antibodies, tipped as having huge potential in China

Deutsche Bank analysts expect to see substantial growth opportunities in China’s monoclonal antibodies (mAbs) market in the coming five years, naming 3SBio and Shanghai Fosun Pharmaceutical as among the first-movers in the sector. Monoclonal antibodies …
( read original story …)

Related Post